Posts | Comments

The Retinal Imaging Devices Market size is expected to reach $6.3 billion by 2025 – KBV Research

Contact Us
KBV Research
244 Fifth Avenue, Suite 1407 New York, N.Y. 10001
New York
New York, N.Y. 10001 
United States
Phone:+1 (646) 661-6066

According to a new report Retinal Imaging Devices Market, published by KBV Research, The Retinal Imaging Devices Market size is expected to reach $6.3 billion by 2025, rising at a market growth of 6.6% CAGR during the forecast period. The market for retinal imaging products is driven primarily by an increase in the prevalence of retinal disorders worldwide, high rates of diagnosis and treatment of retinal disorders, advances in technology, and improved health care infrastructure.

The fundus camera recorded the largest market share in the type segment of the market during 2018. The dominant market share of this sub-segment can be associated with the advantages of this product like portability and ergonomics. The Fluorescein Angiography market is expected to witness a CAGR of 6.7% during (2019-2025).

Hospitals had the largest market share within the end-use segment in 2018. Extensive adoption of advanced retinal imaging devices is anticipated to drive segment growth. In addition, large hospitals are deploying innovative retinal imaging systems to improve early diagnosis of ophthalmic disorders. The segment of ophthalmic centers is expected to rise at an exponential growth rate over the forecast period. Increasing prevalence of eye-related disorders and the availability of quality eye care are factors that result in increased demand for small ophthalmic clinics.

North America captured a substantial share of the overall market for retinal imaging devices in 2018. The high prevalence of ophthalmic disorders, the increased rate of adoption of advanced technology, as well as the presence of a large number of players in the market are factors that contribute to the dominant market share. The Asia Pacific region has been estimated to grow at 7.1% CAGR in the forecast period. The advent of healthcare facilities in the region, together with an increasing awareness of retinal imaging in countries like China, India, and Thailand, is expected to escalate the regional growth. Highly developed health care, strong research, and development system and a rise in retinal disorders are the prominent factors that contributed to a dominant market share of Germany, France, and the United Kingdom in the European region.

Structural Insights:

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Topcon Corporation, Carl Zeiss AG, Olympus Corporation, Robert Bosch GmbH (Bosch Healthcare), Revenio Group Oyj (CenterVue SpA), Nikon Corporation (Optos PLC), Optomed PLC, Epipole Ltd., Nidek Co., Ltd., and Eyenuk, Inc.

Retinal Imaging Devices Market Segmentation
By Type
• Fundus Camera
• Fluorescein Angiography
• OCT (Optical Coherence Tomography)

By End Use
• Hospitals
• Ophthalmic Centers
• ASCs (Ambulatory Surgery Centers)
• Other End Use

By Geography
North America
• US
• Canada
• Mexico
• Rest of North America

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• South Korea
• Singapore
• Australia
• Rest of Asia Pacific

• Brazil
• Argentina
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Companies Profiled
• Topcon Corporation
• Carl Zeiss AG
• Olympus Corporation
• Robert Bosch GmbH (Bosch Healthcare)
• Revenio Group Oyj (CenterVue SpA)
• Nikon Corporation (Optos PLC)
• Optomed PLC
• Epipole Ltd.
• Nidek Co., Ltd.
• Eyenuk, Inc

Leave a Reply